Kanion Pharmaceutical (China)
In research, Kanion Pharmaceutical (China) stands highest in Life Sciences (#4,099 of 11,023 worldwide), Health Sciences (#7,375 of 16,688 worldwide) and Medicine (#8,058 of 14,558 worldwide), over all time. Relative to its size it is most specialised in Molecular Biology (Molecular Biology is 6.8× its share of world research).
- World rank, 2022-now
- #20,754 of 22,385 · #13,503 all time
- Rank in China
- #2,337 of 2,481
- Research works
- 530 ▲ 10% vs 2018-21
- Citations
- 6.7k 12.7 per fractional work
- Top-10% rate
- 10.4% all institutions 10.0%
- vs its own fields
- 0.99× 1.00× is exactly expected
- Open access
- 20% world 40%
- International
- 6% world 18%
What is Kanion Pharmaceutical (China) known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| Life SciencesDomain | #4,099 of 11,023 | 7.1% | 247 | |
| Health SciencesDomain | #7,375 of 16,688 | 7.2% | 201 | |
| MedicineField | #8,058 of 14,558 | 7.3% | 194 |
Each strip is that field's whole ranked pool, with the notch where Kanion Pharmaceutical (China) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).
Which fields of science does Kanion Pharmaceutical (China) work in?
In 2022-now, 51% of research at Kanion Pharmaceutical (China) is in Life Sciences, 30% in Health Sciences. Its largest fields are Medicine (29%), Biochemistry, Genetics and Molecular Biology (27%), Pharmacology, Toxicology and Pharmaceutics (9%). It does 3.4× the world's share of Life Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 22 fields, with their numbers
- Life Sciences6050.9%
- Health Sciences3630.3%
- Medicine3428.9%
- Nursing10.6%
- Health Professions10.5%
- Veterinary00.3%
- Physical Sciences2117.8%
- Chemistry87.0%
- Engineering53.8%
- Computer Science32.8%
- Environmental Science32.2%
- Materials Science11.0%
- Earth and Planetary Sciences10.7%
- Energy00.2%
- Chemical Engineering00.1%
- Social Sciences10.9%
What does Kanion Pharmaceutical (China) specialise in?
Where its research is concentrated relative to its size: Molecular Biology takes 6.8× the share of its output that it takes of world research.
- Molecular BiologySubfield · 24.3 works6.8×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 25.2×. Every wedge is a field page.
All 22 fields, with their numbers
- Pharmacology, Toxicology and Pharmaceutics25.24×10 works
- Biochemistry, Genetics and Molecular Biology5.05×32 works
- Chemistry4.45×8 works
- Immunology and Microbiology3.41×4 works
- Veterinary2.09×0 works
- Agricultural and Biological Sciences1.87×10 works
- Neuroscience1.72×3 works
- Medicine1.51×34 works
- Nursing1.25×1 works
- Decision Sciences0.51×1 works
- Earth and Planetary Sciences0.45×1 works
- Environmental Science0.44×3 works
- Computer Science0.36×3 works
- Materials Science0.28×1 works
- Chemical Engineering0.27×0 works
- Engineering0.26×4 works
- Energy0.20×0 works
- Health Professions0.19×1 works
- Psychology0.05×0 works
- Economics, Econometrics and Finance0.04×0 works
- Business, Management and Accounting0.01×0 works
- Social Sciences0.01×0 works
- Pharmacology, Toxicology and Pharmaceutics 25.2×
- Biochemistry, Genetics and Molecular Biology 5.0×
- Chemistry 4.5×
- Immunology and Microbiology 3.4×
- Veterinary 2.1×
- Agricultural and Biological Sciences 1.9×
- Neuroscience 1.7×
- Medicine 1.5×
- Nursing 1.2×
- Decision Sciences 0.5×
- Earth and Planetary Sciences 0.5×
- Environmental Science 0.4×
- Computer Science 0.4×
- Materials Science 0.3×
- Chemical Engineering 0.3×
- Engineering 0.3×
- Energy 0.2×
- Health Professions 0.2×
- Psychology 0.1×
- Economics, Econometrics and Finance 0.0×
- Business, Management and Accounting 0.0×
- Social Sciences 0.0×
Who are the top researchers at Kanion Pharmaceutical (China)?
Ranked on the quality score, Zeyu Cao, Qian Zhao and Haibo Li lead among researchers whose main affiliation is Kanion Pharmaceutical (China).
- 1
Zeyu Cao
China · #1,333,863 worldwide 2.1k citations · 70 works
- 2
Qian Zhao
China · #1,382,487 worldwide 796 citations · 44 works
- 3
Haibo Li
China · #1,566,840 worldwide 1.2k citations · 76 works
- 4
Wei Lie Xiao
China · #2,876,802 worldwide 1k citations · 66 works
- 5
Wei Xiao
China · #3,106,728 worldwide 413 citations · 21 works
- 6
Xue Xie
China · #3,298,474 worldwide 124 citations · 25 works
- 7
Yukai Cao
China · #3,376,549 worldwide 181 citations · 18 works
- 8
Zhen-Zhen Su
China · #3,459,250 worldwide 292 citations · 27 works
- 9
Xialin Chen
China · #3,598,518 worldwide 946 citations · 94 works
- 10
Mengyu Qian
China · #3,696,691 worldwide 243 citations · 52 works
Which keywords describe research at Kanion Pharmaceutical (China)?
By fractional works in 2022-now, weighted toward what it does more of than the world: Antioxidant, Cancer, Anti-inflammatory, Inflammation, Herbal Medicine, Traditional Chinese Medicine, Antiviral and Bioactive Compounds.
- Iridoids
- Mass Spectrometry
- Genomic Analysis
- Pharmacological Properties
- Adjuvants
- Quality Control
- Neuroprotective Effects
- Neuroprotective
- Glycyrrhizin
- Anticancer
- Precision Medicine
- Medicinal Plants
- Pharmacological Effects
- Hepatoprotective
- Antioxidant Activity
- Phytochemistry
- Bioactive Compounds
- Traditional Chinese Medicine
- Anti-inflammatory
- Cancer
- Antioxidant
- Inflammation
- Herbal Medicine
- Antiviral
- Pharmacology
- Oxidative Stress
- Biological Activities
- Pharmacokinetics
- Flavonoids
- Metabolism
- Apoptosis
- Cardiovascular Disease
- Licorice
- Triterpenoids
- Chemical Analysis
- Saponins
- Ethnopharmacology
- Reactive Oxygen Species
- Genomics
- Data Analysis
Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Antioxidant19▲ 23×26 topics
- Cancer18▲ 11×34 topics
- Inflammation14▲ 5.7×43 topics
- Anti-inflammatory13▲ 40×16 topics
- Herbal Medicine10▲ 32×7 topics
- Traditional Chinese Medicine10▲ 74×5 topics
- Antiviral10▲ 106×3 topics
- Bioactive Compounds10▲ 33×5 topics
- Pharmacology9▲ 30×15 topics
- Phytochemistry8▲ 56×4 topics
- Oxidative Stress8▲ 3.9×30 topics
- Antioxidant Activity7▲ 9.5×13 topics
- Biological Activities7▲ 37×5 topics
- Hepatoprotective7▲ 66×3 topics
- Pharmacokinetics7▲ 21×9 topics
- Pharmacological Effects6▲ 84×5 topics
- Flavonoids6▲ 21×9 topics
- Medicinal Plants6▲ 13×9 topics
- Metabolism6▲ 9.6×16 topics
- Precision Medicine6▲ 9.6×5 topics
- Apoptosis5▲ 15×13 topics
- Anticancer5▲ 28×10 topics
- Cardiovascular Disease5▲ 4.0×7 topics
- Glycyrrhizin5▲ 127×1 topic
- Licorice5▲ 127×1 topic
- Neuroprotective4▲ 22×10 topics
- Triterpenoids4▲ 55×3 topics
- Neuroprotective Effects4▲ 22×7 topics
- Chemical Analysis4▲ 58×1 topic
- Quality Control4▲ 18×1 topic
- Saponins4▲ 87×2 topics
- Adjuvants4▲ 97×1 topic
- Ethnopharmacology4▲ 55×3 topics
- Pharmacological Properties4▲ 37×1 topic
- Reactive Oxygen Species3▲ 6.6×10 topics
- Genomic Analysis3▲ 9.7×4 topics
- Genomics3▲ 8.3×3 topics
- Mass Spectrometry3▲ 16×3 topics
- Data Analysis3▲ 9.1×3 topics
- Iridoids3▲ 73×1 topic
Which research topics does Kanion Pharmaceutical (China) publish most on?
By volume in 2022-now: Pharmacological Effects of Natural Compounds, Traditional Chinese Medicine Analysis, Natural product bioactivities and synthesis and Phytochemistry and Biological Activities.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Pharmacological Effects of Natural Compounds Pharmacology 5 works
- 2 Traditional Chinese Medicine Analysis Complementary and alternative medicine 4 works
- 3 Natural product bioactivities and synthesis Molecular Biology 4 works
- 4 Phytochemistry and Biological Activities Plant Science 3 works
- 5 Traditional Chinese Medicine Studies Complementary and alternative medicine 3 works
- 6 Metabolomics and Mass Spectrometry Studies Molecular Biology 2 works
- 7 Gut microbiota and health Molecular Biology 2 works
- 8 Chromatography in Natural Products Analytical Chemistry 2 works
- 9 Computational Drug Discovery Methods Computational Theory and Mathematics 2 works
- 10 Ginger and Zingiberaceae research Pharmacology 1 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Kanion Pharmaceutical (China)'s research output changed?
Output in 2022-2025 was 10% higher than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Kanion Pharmaceutical (China) as a percentage of every work published that year, 0.00053% in 2024.
Fractional works of Kanion Pharmaceutical (China) over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year, against all institutions in the same year.
Of each year's output, the share that reached the world's 10% most cited for its field and year. Peak 15.0% in 2022.
Other research institutions in Lianyun
- The First People’s Hospital of Lianyungang
- Lianyungang Maternal and Children’s Hospital
- Hansoh Pharma (China)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Kanion Pharmaceutical (China). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.
